Wolverine Asset Management LLC Esperion Therapeutics, Inc. Put Options Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 08, 2023	BUY	$1.46 - $7.3 $292 - $1,460	200 New	200 $0
Q2 2022 Aug 03, 2022	SELL	$4.77 - $6.67 $20,510 - $28,681	-4,300 Reduced 13.4%	27,800 $176,000
Q1 2022 May 04, 2022	BUY	$3.34 - $5.56 $76,152 - $126,767	22,800 Added 245.16%	32,100 $148,000
Q4 2021 Feb 09, 2022	BUY	$4.81 - $11.92 $33,670 - $83,440	7,000 Added 304.35%	9,300 $46,000
Q3 2021 Nov 12, 2021	BUY	$11.34 - $21.37 $12,474 - $23,507	1,100 Added 91.67%	2,300 $27,000
Q1 2021 May 13, 2021	BUY	$25.12 - $36.89 $30,144 - $44,268	1,200 New	1,200 $33,000

209

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $140M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.